Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
04/2006
04/19/2006EP1646629A2 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
04/19/2006EP1646621A2 Novel azaheterocyclic amides useful for treating pain
04/19/2006EP1646615A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
04/19/2006EP1646614A2 Ophthalmic compositions for treating ocular hypertension
04/19/2006EP1646380A2 Indolocarbazole anticancer agents and methods of using same
04/19/2006EP1537112B1 Condensed pyridines and pyrimidines with tie2 (tek) activity
04/19/2006EP1534711B1 Phenyl-substituted pyrazolopyrimidines
04/19/2006EP1468050B1 Water-soluble phthalocyanine compound-containing ink for ink jetting, ink jet recording method and method for improving ozone gas discoloration of colored image material
04/19/2006EP1463730B1 Pyrazolopyridazine derivatives
04/19/2006EP1448564B1 Substituted indolizine-like compounds and methods of use
04/19/2006EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents
04/19/2006EP1189890B1 Dihydrobenzodiazepins and their use for treating dyslipidemia
04/19/2006EP1097152B1 Synthesis of compounds useful in the manufacture of ketorolac
04/19/2006EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants
04/19/2006CN1761666A Polyhydroxylated pyrrolizidine
04/19/2006CN1761665A Antitumor effect potentiator and antitumor agent
04/19/2006CN1761664A Immunomodulating heterocyclic compounds
04/19/2006CN1761651A 2,4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives
04/19/2006CN1761642A Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation
04/19/2006CN1761394A Synergistically acting herbicidal mixtures
04/19/2006CN1252072C Method for prodn. Of 4, 6-diaminopyrimido [5, 4-D] pyrimidines
04/19/2006CN1252047C Benzene sulfonic derivative
04/18/2006US7030239 Compounds to treat Alzheimer's disease
04/18/2006US7030138 Benzamidine derivatives
04/18/2006US7030128 Imidazo-pyrimidine derivatives as ligands for GABA receptors
04/18/2006US7030125 useful in the treatment of TGF- beta related disease states including, for example, cancer and fibrotic diseases
04/18/2006US7030122 1,4-disubstituted piperazine ligands for neurotransmitter receptors
04/18/2006US7030121 Pyrazolopyrazine compound and pharmaceutical use thereof
04/18/2006US7030118 Pyrrolotriazinone compounds and their use to treat diseases
04/18/2006US7030112 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
04/18/2006US7030109 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
04/18/2006US7029835 Photothermographic element comprising improved base precursors and methods for their use
04/18/2006US7029658 Delivery of antidepressants through an inhalation route
04/18/2006CA2360943C N2-phenylamidine derivatives
04/18/2006CA2241852C Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon
04/18/2006CA2037098C Hexahydrobenz ¢cd! indoles and processes for preparation thereof
04/13/2006WO2006039639A1 Crystalline forms and process for preparing spiro-hydantoin compounds
04/13/2006WO2006008251A3 Process for the photoactivation and use of a catalyst by an inverted two-stage procedure
04/13/2006WO2006004931A3 Substituted azepine derivatives as serotonin receptor modulators
04/13/2006WO2005118549A3 Compounds having affinity for dopamine d3 receptor and uses thereof
04/13/2006WO2005116032A3 Reverse-turn mimetics and method relating thereto
04/13/2006WO2005103052A8 Pyrazolo [1,5-a] pyrimidin-7-one compounds and uses thereof
04/13/2006US20060079680 Pyrazoloazepine compounds as pharmaceutical agents
04/13/2006US20060079677 Novel tricyclic azepine derivatives, method for production thereof and pharmaceutical compositions comprising the same
04/13/2006US20060079549 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength
04/13/2006US20060079537 2-Substitutued triazolopyrimidines, methods and intermediate products for the production thereof, the use of the same controlling pathogenic fungi, and agents containing said compounds
04/13/2006US20060079536 Calcium receptor modulating compound and use thereof
04/13/2006US20060079530 Farnesyl transferase inhibitors
04/13/2006US20060079527 Compounds such as 1-[4-(3,4-difluoro-phenyl) -piperazin-1 -yl]-3-{methyl-[2-(9H-xanthen-9-yl)-ethyl]-amino}-propan-1 -one in free base or acid addition salt form, for therapy of depression, anxiety and bipolar disorders
04/13/2006US20060079520 Sulfonamide peri-substituted bicyclics for occlusive artery disease
04/13/2006US20060079517 Reverse-turn mimetics and methods relating thereto
04/13/2006US20060079511 7,8-Disubstituted pyrazolobenzodiazepines
04/13/2006US20060079507 Substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives
04/13/2006US20060079503 Thiazolidinones and the use therof as polo-like kinase inhibitors
04/13/2006US20060079498 ((2S,4S)-4-(4-(3-(Trifluoromethyl)phenyl)piperazin-1-yl)pyrrolidin-2-yl)-(3,3-difluoropyrrolidin-1-yl)-methanone dihydrochloride; dipeptidyl peptidase-IV inhibitor; diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy
04/13/2006US20060079496 Agglomerates by crystallisation
04/13/2006US20060078756 Assembled hematin, method for forming same and method for polymerizing aromatic monomers using same
04/13/2006US20060075585 Rylene dyes
04/13/2006US20060075584 Using for analysis; detecting aging, applying compound having a tetraazaporphyrin skeleton onto a base material, the bicyclo compound being converted to an organic semiconductor on the base material through retro-Diels-Alder reaction
04/12/2006EP1645552A1 Double-spiro organic compounds and electroluminescent devices
04/12/2006EP1644379A1 Rotaxane compound, rotaxane-bonded solid substrate, and biochip using the same
04/12/2006EP1644378A2 Method for producing alkoxy-substituted phthalocyanins
04/12/2006EP1644377A1 Triazolotriazine compounds and uses thereof
04/12/2006EP1644376A1 PYRROLO 3,4-c PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS
04/12/2006EP1644375A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
04/12/2006EP1644374A1 Triazolopyrimidines
04/12/2006EP1644344A1 Method of preparing cis-8b-methyldecahydro-2a,4a,6a,8a-tetraazacyclopenta [fg]acenaphthylene, cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta [fg]acenaphthylene, cyclene and functionalised cyclenes
04/12/2006EP1644343A1 5-substituted quinazolinone derivatives
04/12/2006EP1644337A1 Melanocortin-4 receptor binding compounds and methods of use thereof
04/12/2006EP1644003A1 Triazolo ´1,5-a!pyrimidines and their use in medicine
04/12/2006EP1643998A1 Dual nk1/nk3 antagonists for treating schizophrenia
04/12/2006EP1643836A1 Arylmethyl triazolo and imidazopyrazines as c-met inhibitors
04/12/2006EP1054887B1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
04/12/2006EP1005356B1 Novel antibacterial agents
04/12/2006CN1759118A Diazepinoindole derivatives as kinase inhibitors
04/12/2006CN1759117A Pyrrolopyridazine derivatives
04/12/2006CN1759116A Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
04/12/2006CN1757646A Inhibitors of nucleoside metabolism
04/12/2006CN1250558C Improved method for preparing crosslinke endomarcocyclic compound
04/12/2006CN1250551C Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
04/12/2006CN1250550C Process for preparation of amidine derivatives
04/12/2006CN1250549C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
04/12/2006CN1250544C Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods
04/12/2006CN1250294C Photosensitive and method for production thereof
04/12/2006CN1250223C Pyrrolo-triazine and pyrimidine compounds
04/11/2006US7026488 A hemeoxygenase inhibitory metalloprotoporphyrin derivative, especially Zn-protoporphyrin, conjugated with an amphipathic or water soluble polymer; anticarcinogenic agents with little side effect and excellent tumor accumulation; very potent and efficient; administered by intravenous injection; stability
04/11/2006US7026478 Iron catalyzed cross coupling reactions of aromatic compounds
04/11/2006US7026347 Porphyrin-polyamine conjugates for cancer therapy
04/11/2006US7026331 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct
04/11/2006US7026318 Compounds exhibiting X-type sPLA2 inhibiting effect
04/11/2006US7026317 bind to corticotropin releasing factor (CRF) receptors; psychological disorders; anxiety-related disorders; central nervous system disorders
04/11/2006US7026311 Dibenzodiazepine derivatives, their preparation and use
04/06/2006WO2006036883A2 Imidazo{4,5-b}pyrazinone inhibitors of protein kinases
04/06/2006WO2006036024A1 Proton pump inhibitors
04/06/2006WO2006034848A1 7-aminomethyl-1,2,4-triazolo[1,5-a]pyrimidine compounds and their use for controlling pathogenic fungi
04/06/2006WO2006004724A3 A method for preparing pyrrolotriazine compounds
04/06/2006WO2005123737A9 Charge-transport materials, methods of fabrication thereof, and methods of use thereof
04/06/2006WO2005113554A3 Method of preparing 3-phenyl-2-[9h-purin-6-ylamino)-methyl]-3h-quinazolin-4-one and substituted and related compounds
04/06/2006WO2005095404A3 6-(2-fluorophenyl)-triazolopyrimidines, method for producing them, their use for controlling parasitic fungi and agents containing the same
04/06/2006WO2005061501A3 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds